Glutathione IV Therapy in San Diego Premier Cellular Health Support HELPS TARGET: Weakned immune system, detoxification, brain fog, increased energy, poor sleep, muscle/joint pain, detoxification of liver KEY MEDICINES: Glutathione Detoxification Muscle/joint pain Increased energy Poor sleep Why Is Glutathione IV Infusion Effective: Glutathione delivered intravenously is the fastest and most effective way of boosting glutathione levels
Denial patterns appear when: Functional impairment is missing from the record Objective strength findings are absent Repeated use continues without updated findings or diagnostic clarification ICD-10 does not support the intensity/type of billed services Medicare and Payer Perspective on M62.81 Medicare and commercial payers expect: Objective findings supporting weakness functional limitation supporting treatment progression tracking when services continue over time diagnosis refinement when evaluation identifies a cause Common payer red flags: weakness was stated only in the subjective section No strength testing was documented therapy billed without functional goals tied to deficits M62.81 was used repeatedly without an updated assessment Common Claim Denials Linked to M62.81 Denials typically tie to documentation gaps rather than the code itself: Missing objective strength findings Missing ADL or mobility impact Weak plan-of-care connection to billed services Non-specific coding when a specific cause is documented elsewhere in the record No progress reporting for continued therapy Denial prevention comes from structured charting, consistent reassessment, and CPT-to-diagnosis alignment
A clinical study found that taking liposomal glutathione raised glutathione levels in the blood by up to 40% within two weeks, and contributed to improvements in immune function and measurable drops in oxidative stress
The FDA has also flagged BPC-157 in the context of bulk substances that may pose significant safety risks, especially in compounding environments
